Aromatase inhibitor use is a risk factor of carotid plaque presence in endocrine-responsive breast cancer patients

BACKGROUND/AIMS: The aromatase inhibitors (AIs) are well known anti-hormonal therapy in endocrine-responsive breast cancer patients. It can lead to dyslipidemia and be the risk factor of cardiovascular disease due to low estrogen level. However, some recent studies comparing AIs with placebo have sh...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Korean J Intern Med
Main Authors: Seo, Da Hea, Cho, Yongin, Lee, Sujin, Park, Seho, Kim, Seung-Il, Park, Byeong Woo, Rhee, Yumie
Format: Artigo
Jezik:Inglês
Izdano: The Korean Association of Internal Medicine 2019
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6506747/
https://ncbi.nlm.nih.gov/pubmed/28838227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2016.205
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki